Olink Proteomics’ Post

Protein biomarkers are a powerful tool in precision medicine. As the role of proteomics grows in the advancement of personalized healthcare, the need for a well-structured assay development pipeline has become increasingly critical. Our latest White Paper explores important considerations for biomarker selection and assay development, such as: - Key criteria for selecting relevant biomarkers - Current challenges and opportunities in assay development - Practical steps for planning robust and impactful biomarker studies Below are the first two pages—take a sneak peek. Download the full white paper to explore the science in greater depth:https://bit.ly/4eF3nHq #PoweredByOlink